The Tunisian ANMPS has published a new questionnaire addressed to Marketing Authorization Holders (MAHs) as part of the ongoing strengthening of Pharmacovigilance and regulatory compliance activities in Tunisia. This initiative further highlights the importance of maintaining robust local PV oversight and effective regulatory support through qualified local partners.   These two questionnaires were developed to collect accurate and relevant information to guide future actions, improve current practices, […]

In June 2025, Tunisia’s National Agency for Medicines and Health Products (ANMPS) released a new official guide titled:  Regulatory Compliance, Reliance, and Pharmacovigilance Guide. The guide outlines the regulatory […]

On June 4th, 2025, the National Agency for Medicines and Health Products (ANMPS) officially published the updated version of the Human Medicines Registration Guide in Tunisia. Download the […]

Arema is pleased to announce its participation in a training session presented with its partner EXTEDO  and in collaboration with the Tunisian National Chamber of the Pharmaceutical Industry (CNIP). […]

The Egyptian Drug Authority (EDA) and the South African Health Products Regulatory Authority (SAHPRA) have announced the reopening of their joint pilot project for the collaborative […]

AREMA is proud to have taken part in the 24th edition of FPI Tunis 2025 event (Forum Pharmaceutique International). FPI Tunis 2025 is a remarkable, huge […]

On April 16, 2025, AREMA will participate in the A3P Tunisia Forum, in partnership with Extedo.  This forum is about:  e-CTD / The new global guidelines […]

Tunisian National Agency for Medicines and Health Products (ANMPS) issued an urgent and important note by 10 April 2025 reminding all pharmaceutical companies to comply with pharmacovigilance […]